Enzalutamide treatment and risk for seizures

The “Warnings and Precautions” section of the product prescribing information for enzalutamide (Xtandi) includes the following statement: … READ MORE …

Astrology and the interpretation of data from clinical trials

Over the weekend, an  interesting article on clinical trials appeared (somewhat unexpectedly) in the New York Times color supplement. … READ MORE …

Double your donation for prostate cancer research

We are always delighted when our readers and friends are willing to support the services we provide through Prostate Cancer International. However, we aren’t dumb! We are also very understanding of the fact that many of you would rather support prostate cancer research! So … here’s something you should know about. … READ MORE …

Raphael (“Ralph”) Valle … R.I.P.

It has just been brought to our attention that Ralph Valle passed away on September 6 this year “after a long illness”, which we can assume to have been his prostate cancer. … READ MORE …

Chance and progress in the treatment of cancer

Those readers who have limited knowledge of how “translational research” often occurs and progresses (or fails) — particularly in the field of cancer therapy — might like to read this article by Rosenbaum in this week’s issue of The New England Journal of Medicine. … READ MORE …

FDA approves CAR T-cell therapy for treatment of acute lymphoblastic leukemia

Within the past few hours, the US Food and Drug Administration (FDA) has approved the very first form of chimeric antigen receptor (CAR) T-cell therapy for the treatment of cancer — and this is also the first true form of gene therapy to be made available here in the US. … READ MORE …

Hiatus in new posts to the InfoLink site

Your sitemaster apologizes for a recent hiatus in new posts to the InfoLink site. He has been away from the office for the past 10 days dealing with some personal matters. He hopes to start “catching up” tomorrow!